Chronic kidney disease in adults [QS5]

Measuring the use of this guidance

Statement: 1

Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. [2011, updated 2017]

Quality standard measure: Proportion of adults with CKD who had ACR testing at the frequency agreed with their healthcare professional.

What was measured: Proportion of patients on the CKD register whose notes have a record of a urine albumin:creatinine ratio (or protein:creatinine ratio) test in the preceding 12 months.

Data collection end: March 2018

37.2%

Number that met the criteria: 592940 / 1593368

Area covered:	England
Source:	Indicators no longer in QOF (INLIQ)

View quality statement history

Statement: 2

Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. [2011, updated 2017]

Quality standard measure: Proportion of adults with CKD without diabetes and with an ACR below 70 mg/mmol whose systolic blood pressure is between 120–139 mmHg and their diastolic blood pressure below 90 mmHg.

What was measured: Proportion of patients on the CKD register in whom the last blood pressure reading (measured in the preceding 12 months) is 140/85 mmHg or less.

Data collection end: March 2018

65.5%

Number that met the criteria: 1043942 / 1593368

Area covered:	England
Source:	Indicators no longer in QOF (INLIQ)

Quality standard measure: Proportion of adults with CKD and diabetes whose systolic blood pressure is between 120–129 mmHg and their diastolic blood pressure below 80 mmHg.

What was measured: Proportion of people with CKD stage 3 to 5 with diabetes who had a below target blood pressure reading recorded.

Data collection end: June 2016

29.2%

Area covered:	England and Wales
Source:	National Chronic Kidney Disease Audit.

View quality statement history

Archived quality statements

Quality statements that are no longer current have been archived.

View archived quality statements

Previous number Quality statement: 1

View quality statement

Archive date 31 July 2017

People with risk factors for CKD are offered testing, and people with CKD are correctly identified

Quality standard measure: Proportion of people with risk factors for CKD who receive testing

What was measured: Proportion of patients with diabetes whose GP practices tested their serum creatinine levels on an annual basis

Data collection end: June 2016

85.9%

Area covered:	England and Wales
Source:	National Chronic Kidney Disease Audit.

Quality standard measure: Proportion of people with risk factors for CKD who receive testing

What was measured: Proportion of patients with diabetes whose GP practices tested their urinary albumin/creatinine ratio on an annual basis.

Data collection end: June 2016

53.9%

Area covered:	England and Wales
Source:	National Chronic Kidney Disease Audit.

Previous number Quality statement: 2

View quality statement

Archive date 31 July 2017

People with CKD who may benefit from specialist care are referred for specialist assessment in accordance with NICE guidance

Quality standard measure: Proportion of people with CKD in defined at‑risk groups who are referred for specialist assessment

What was measured: Proportion of people with CKD in high risk groups who have a specialist referral recorded

Data collection end: June 2016

33.5%

Area covered:	England and Wales
Source:	National Chronic Kidney Disease Audit.

Quality standard measure: Incidence of cardiovascular events for people with CKD.

What was measured: Hospitalisations due to acute and chronic ischaemic heart disease in people with coded and uncoded CKD stages 3-5.

Data collection end: June 2016

37.8%

Area covered:	England and Wales
Source:	National Chronic Kidney Disease Audit.

Quality standard measure: Incidence of cardiovascular events for people with CKD.

What was measured: Hospitalisations due to cerebrovascular disease or TIA in people with coded and uncoded CKD stages 3-5.

Data collection end: June 2016

27.4%

Area covered:	England and Wales
Source:	National Chronic Kidney Disease Audit.

Quality standard measure: Incidence of cardiovascular events for people with CKD.

What was measured: Hospitalisations due to heart failure in people with coded and uncoded CKD stages 3-5.

Data collection end: June 2016

27.1%

Area covered:	England and Wales
Source:	National Chronic Kidney Disease Audit.

Quality standard measure: Incidence of cardiovascular events for people with CKD.

What was measured: Hospitalisations due to peripheral and aortic artery disease in people with coded and uncoded CKD stages 3-5.

Data collection end: June 2016

7.7%

Area covered:	England and Wales
Source:	National Chronic Kidney Disease Audit.

Return to QS5 Overview